David P Ellent PLLC

David P Ellent PLLC was paid $502K by Medicaid between Jun 2020 and Dec 2024, across 51 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 40% of everything it billed.

Compared with peers

Next to other Hematology & Oncology Physician providers in Texas

Rank by total paid#5 of 49

Median peer was paid$15K

This provider vs. median33×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	3,414	$112K
2021	7,472	$168K
2022	2,314	$54K
2023	4,640	$112K
2024incomplete	3,501	$56K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	40%	4,830	3,555	$202K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	16%	2,874	2,502	$80K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	12%	1,485	1,389	$61K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	6.1%	1,335	960	$31K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	5.6%	1,721	1,458	$28K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	4.2%	1,036	675	$21K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	2.2%	499	253	$11K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	1.8%	122	113	$9K
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	1.7%	185	178	$9K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	1.3%	598	461	$7K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.2%	179	145	$6K
81514		1.2%	93	91	$6K

39 more codes

U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	1.2%	582	$6K
99441		1.1%	723	$6K
99233	Hospital visit by a doctor, follow-up day (complex)	1.1%	308	$5K
99442		<1%	150	$2K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	65	$2K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	474	$2K
87276		<1%	454	$1K
87529		<1%	158	$1K
87563		<1%	185	$1K
87275		<1%	454	$1K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	15	$1K
87653		<1%	199	$899.97
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	91	$655.99
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	91	$655.99
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	58	$611.72
87640		<1%	79	$598.50
80061	Lipid panel	<1%	41	$310.50
87481		<1%	78	$176.88
80053	Comprehensive metabolic panel	<1%	35	$137.93
80305		<1%	16	$137.54
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	14	$125.27
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	71	$123.03
83036	Hemoglobin; glycosylated (A1C)	<1%	14	$94.66
87500		<1%	39	$58.96
87641		<1%	38	$58.96
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	332	$16.75
1036F		0%	231	$0.00
3008F		0%	501	$0.00
3074F		0%	209	$0.00
3079F		0%	12	$0.00
1126F		0%	82	$0.00
1111F		0%	80	$0.00
3078F		0%	178	$0.00
1159F		0%	92	$0.00
G0444	Annual depression screening, 5 to 15 minutes	0%	25	$0.00
1160F		0%	118	$0.00
G8427	Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications	0%	51	$0.00
G0312	Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service for ages under 21, 5 to 15 mins time (this code is used for medicaid billing purposes)	0%	14	$0.00
99173		0%	27	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialELLENT, DAVID (FOUNDER)